ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 316

Cytokines in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome: Tipping the Balance Between Interleukin-18 and Interferon-Gamma

Karen Put1, Anneleen Avau1, Ellen Brisse1, Tania Mitera1, Stéphanie Put1, Paul Proost2, Brigitte Bader-Meunier3, Rene Westhovens4, Benoît Van den Eynde5, Ciriana Orabona6, Francesca Fallarino6, Lien De Somer7, Thomas Tousseyn8, Pierre Quartier3, Carine Wouters7 and Patrick Matthys1, 1University of Leuven, Laboratory of Immunobiology, Rega Institute, Leuven, Belgium, 2University of Leuven, Laboratory of Molecular Immunology, Rega Institute, Leuven, Belgium, 3Pediatric Rheumatology, IMAGINE Institute, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Université Paris-Descartes, Paris, France, 4University of Leuven, Skeletal Biology and Engineering Research Center, Department of Development and Regeneration; Rheumatology, University Hospital Leuven, Leuven, Belgium, 5Institut de Duve, Université catholique de Louvain, Brussels, Belgium, 6Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Perugia, Italy, 7University of Leuven, Laboratory of Pediatric Immunology, University Hospital Leuven, Leuven, Belgium, 8University of Leuven, Department of Imaging and Pathology, Leuven, Belgium

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Cytokines and macrophage activation syndrome, Systemic JIA

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Pathogenesis and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose

To study the role of interferon-gamma (IFN-γ) in the pathogenesis of systemic juvenile idiopathic arthritis (sJIA) and macrophage activation syndrome (MAS) by searching for an IFN-γ profile and assess its relation with other cytokines.

Methods

Patients with inactive (n=10) and active sJIA (n=10), MAS (n=5) and healthy controls (n=16) were enrolled in the study. Cytokines and IFN-γ-induced proteins were determined in plasma by ELISA and HPLC-MS, in patient peripheral blood mononuclear cells (PBMCs) (qPCR, flow cytometry, western blot and ELISA) and in lymph node biopsies of one patient during both sJIA and MAS episodes (immunohistochemistry). IFN‑γ responses were investigated in healthy donor PBMCs, primary fibroblasts and endothelial cells.

Results

Plasma IFN-γ, IL-6 and IL-18 were elevated in active sJIA and MAS. Levels of IFN‑γ and IFN‑γ-induced proteins (IP‑10/CXCL-10, IL-18BP and IDO) in MAS were highly surpassing levels in active sJIA. Free IL-18 and ratios of IL‑18/IFN-γ were higher in active sJIA versus MAS. MAS PBMCs showed a hyporesponsiveness to IFN-γ in vitro. Endothelial cells and fibroblasts expressed IFN-γ-induced proteins in situ in lymph node stainings of a MAS patient and in vitro upon stimulation with IFN-γ.

Conclusion

Patients with active sJIA and MAS show distinct cytokine profiles with highly elevated plasma levels of IFN-γ and induced proteins typically found in MAS. In addition to PBMCs, histiocytes, endothelial cells and fibroblasts may contribute to an IFN‑γ profile in plasma. Increasing levels of IFN-γ compared to IL-18 may raise suspicion for development of MAS in sJIA.


Disclosure:

K. Put,
None;

A. Avau,
None;

E. Brisse,
None;

T. Mitera,
None;

S. Put,
None;

P. Proost,
None;

B. Bader-Meunier,
None;

R. Westhovens,
None;

B. Van den Eynde,
None;

C. Orabona,
None;

F. Fallarino,
None;

L. De Somer,
None;

T. Tousseyn,
None;

P. Quartier,
None;

C. Wouters,
None;

P. Matthys,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cytokines-in-systemic-juvenile-idiopathic-arthritis-and-macrophage-activation-syndrome-tipping-the-balance-between-interleukin-18-and-interferon-gamma/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology